About Zhejiang Medicine Company

The company is a large-scale joint stock comprehensive pharmaceutical company established in May 1997. In August 1999, with the approval of the China Securities Regulatory Commission, the company publicly issued 58 million RMB A shares to the public. In October of the same year, the company's shares were listed on the Shanghai Stock Exchange. The main business is life nutrition products, pharmaceutical manufacturing products and pharmaceutical businesses. Life nutrition products are mainly synthetic vitamin E, vitamin A, natural vitamin E, vitamin H (biotin), vitamin D3, coenzyme Q10, beta-carotene, cantharaxanthin, lutein, lycopene, etc.; pharmaceutical manufacturing products are mainly pharmaceutical raw materials such as anti-drug resistant antibiotics, antimalarial medicines, quinolones, anti-drug resistant antibiotics, hypoglycemic agents, hormones, etc.; as well as major health products such as lutein, natural vitamin E, and coenzyme Q10; delivered the bid products. Corporate honors: “2017 China's Best Industrial Enterprise in Pharmaceutical R&D Product Line” (ranked 12th), won the first prize of the China Light Industry Federation Science and Technology Progress Award, “2017 China Pharmaceutical Industry Top 100” (34th), “2017 China's Top 100 Pharmaceutical Businesses” (38th), “2017 China's Top 20 Western Medicine Exporters” ranking (ranked 6th), National Science and Technology Progress Award, etc.